Cairo, July 7, 2025
Alameda Healthcare Group, a leading healthcare provider in Egypt, has signed a binding agreement with Development Partners International (DPI), through funds it advises and its co-investors, for a USD 190 million minority investment in the Group. Representing the largest healthcare investment of its kind in Egypt, this landmark transaction will support Alameda’s next phase of strategic expansion and innovation across both Egypt and the Gulf Cooperation Council (GCC) region.
The transaction, which is primarily a capital increase, remains subject to regulatory and other customary approvals and is expected to close in the third quarter of 2025.
This investment will enable Alameda to expand its geographic footprint, enhance clinical capacity, and invest in advanced medical technologies. The Group will also continue to strengthen its Centers of Excellence, elevate patient care, and introduce high-quality healthcare services to underserved areas, while helping to position Egypt as a regional hub for world-class medical value travel.
Dr. Fahad Khater, Chairman of Alameda Healthcare, commented, “Delivering for patients is at the heart of what we do at Alameda, and this investment will help us to treat more patients with high-quality care. This investment will enable us to expand access to high-quality healthcare across Egypt, particularly in underserved areas, while enhancing our capacity to serve a larger patient population. It also enables us to invest in training and development, helping to retain and attract top medical talent and reverse the brain drain of Egyptian doctors and nurses. With all our hospitals fully JCI-accredited, this investment further enables us to raise the bar in clinical quality and safety across the region. By enhancing Egypt’s position as a destination for medical value travel, we aim to strengthen the country’s role as a regional hub for world-class healthcare services. With DPI’s specialist regional and healthcare experience, we are ideally positioned to launch into our next phase of expansion across the KSA, UAE, and other GCC markets.”
DPI will work in close partnership with Alameda’s leadership team, led by Dr. Khater, who remains the majority shareholder. The partnership will focus on scaling Alameda’s operations, improving access to care, and enhancing clinical standards across Egypt and the broader region through training and talent development initiatives.
Ziad Abaza, Partner at Development Partners International, said, “This is a milestone transaction for Egypt and DPI. We’re delighted to be supporting Dr. Fahad Khater and his mission of delivering world-class healthcare across Egypt and the GCC. We look forward to working closely with our partners and Alameda’s management team to continue growing our family of hospitals and delivering excellent care to patients.”
EFG Hermes acted as the Sole M&A Financial Advisor to Alameda Healthcare. Addleshaw Goddard LLP served as international legal counsel, with ALC Alieldean Weshahi & Partners and Matouk Bassiouny & Hennawy serving as local legal counsels to Alameda. DPI was advised by White & Case LLP as international and local legal counsel, alongside PricewaterhouseCoopers (PwC), Debevoise & Plimpton LLP, and Rothschild & Co.
